Welcome to our dedicated page for Haleon news (Ticker: HLN), a resource for investors and traders seeking the latest updates and insights on Haleon stock.
Haleon plc reports consumer health developments across Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health and Other. The company's news commonly covers product launches and brand activity for names such as Sensodyne, parodontax, Centrum, Advil, TUMS, Theraflu, Voltaren, Polident and Panadol.
Recurring updates include oral-care innovation, multivitamin research, consumer marketing campaigns, regional growth initiatives, manufacturing investment, and leadership changes within the U.S. and other markets. As a foreign issuer with American depositary shares traded under HLN, company announcements may also address parent-company reporting, governance and capital-market communications.
Haleon (LSE/NYSE: HLN) announced the launch of Ticket to Relief, a national consumer education campaign for Voltaren Arthritis Pain Gel, designed to help people understand and manage arthritis joint pain so they can stay active in activities like golf. Actor and golf enthusiast Brian Baumgartner will serve as Voltaren’s lead “Relief Caddie,” using digital, social and live content to discuss joint pain and share educational resources. The campaign debuts at the FM Championship at TPC Boston from August 27-30, 2026, where Voltaren is an official sponsor and presenting sponsor of Friday’s play. Voltaren highlights that, unlike some topicals that numb, heat or cool, its gel penetrates through the skin to the joint to provide temporary arthritis pain relief in several joints.
Haleon (LSE/NYSE: HLN) announced the pricing terms, expiration and preliminary results of its cash tender offer for any and all of the outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027 issued by Haleon US Capital.
As of the 5:00 p.m. New York time expiration on 18 August 2026, holders had tendered $1,342,272,000 principal amount. According to Haleon, accepted notes are expected to receive total consideration of $996.23 per $1,000 principal, based on a 3.921% reference yield and 10 bps fixed spread, plus accrued interest to but excluding the settlement date. The offer is conditioned on completion of a new USD-denominated senior fixed rate notes issuance, with both the new issue and tender offer settlement expected on 21 August 2026. Accepted notes will cease accruing interest on the settlement date and will be cancelled. The notes are fully and unconditionally guaranteed by Haleon.
Haleon (NYSE: HLN), through its Centrum brand, announced Centrum Age Defy, a new multivitamin line formulated for adults ages 35+ to support proactive healthy aging. According to Centrum, Age Defy delivers 16 healthy aging benefits, including heart, brain, immune, energy, metabolism, vascular and cellular health, in two tablets daily.
The formula features resveratrol for vascular health, niacin to support normal NAD+ levels, and 2X the antioxidant vitamins to help defend against everyday oxidative stressors. Centrum positions Age Defy alongside Centrum Silver for adults 50+, and is promoting the launch with Kate Walsh and a New York City “Inside Out” scavenger hunt on August 21. Both Age Defy and Silver are available nationwide at major retailers and online.
Haleon (LSE/NYSE: HLN) announced a cash tender offer by its subsidiary Haleon US Capital LLC to purchase any and all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027, which are fully and unconditionally guaranteed by Haleon.
Holders will receive a price per $1,000 equal to the Total Consideration, calculated using the bid-side yield on the 3.875% U.S. Treasury due March 31, 2027 plus a fixed spread of 10 bps, plus accrued interest to (but excluding) the settlement date. The offer expires at 5:00 p.m. New York City time on 18 August 2026, with price determination expected at 2:00 p.m. the same day and settlement expected on 21 August 2026. The offer is subject to customary conditions, including a New Notes Condition that Haleon US Capital successfully completes a new issue of USD-denominated senior fixed-rate notes. Notes purchased will be cancelled, and tenders are allowed in minimum denominations of $250,000 and integral multiples of $1,000 thereafter.
Haleon (NYSE:HLN), through its Emergen-C brand, announced a summer partnership with Carl Radke’s Soft Bar to promote Emergen-C as the “Drink of the Summer.” The collaboration centers on a limited-time mocktail experience showcasing Emergen-C’s Multi-Benefit Support, including immune support*, natural energy support† and electrolytes‡.
The campaign responds to rising demand for functional beverages, citing an EY survey where 65%** of U.S. adults, including 80%** of Gen Z and 75%** of Millennials, drink functional beverages at least every two weeks. On August 11, select guests at Soft Bar in Brooklyn will sample two Emergen-C-inspired mocktails, Hello Summer and Stay A While, and receive recipes to recreate them at home.
Sensodyne Clinical Repair (NYSE:HLN) is launching the World’s Coldest Treat, a one-day frozen dessert activation in partnership with comedian Michelle Buteau and Chef Simon Davies to spotlight tooth sensitivity and promote its sensitivity-repair toothpaste.
On Thursday, August 6, from 1–7 p.m. EST at 45Grand in SoHo, NYC, guests can “put your teeth to the test” with a liquid-nitrogen-based blueberry and vanilla white chocolate dessert, created at approximately -196°C (-321°F) and served at a food-safe temperature. Each attendee receives a tasting experience, photo moments, and a tube of Sensodyne Clinical Repair, available while supplies last. According to Sensodyne, the toothpaste starts to repair sensitive areas after 60 seconds and, with twice-daily brushing, builds a protective layer for long-lasting relief.
Haleon (HLN) announced a new five-year collaboration with Microsoft to expand digital, data and AI capabilities and support its global Win as One strategy. The partnership uses Microsoft Azure, Copilot and agentic AI to enhance productivity, consumer insights, R&D, supply chain and commercial execution, supporting Haleon’s ambition to reach one billion more consumers by 2030.
NIQ (NYSE:NIQ) released new insights showing that nearly one in three Western consumers now buy products first discovered on social platforms, as AI-driven, discovery-led commerce spreads from East to West.
Retail media has grown into a $184 billion global market, and integrated, AI-enabled commerce ecosystems are reshaping brand and retailer growth strategies.
Advil (NYSE:HLN) launched Rewriting Pain, a 2026 summer campaign challenging sports culture’s “no pain no gain” mentality. Partnering with soccer legend Jozy Altidore, the brand promotes confronting pain responsibly, supported by a survey of 1,000 U.S. everyday athletes highlighting widespread pressure to play through pain.
Haleon (HLN) will invest about £175 million to build its first oral health manufacturing site in Madhya Pradesh, India, and expand rural distribution. The plant is expected to open in early 2028, with supply from 2029, supporting India and wider Asia.
The plan targets over 300 million additional consumers in India, aims to reach 3 million retail outlets by 2030, creates up to 500 factory jobs plus 500 new sales roles, and doubles “last‑mile” motorbike teams delivering affordable products like 20‑rupee Sensodyne packs.